Clinical trial
Argus® II Retinal Stimulation System Feasibility Protocol
NCT00407602 is registered in ClinicalTrials.gov with Second Sight Medical Products as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Argus® II Retinal Stimulation System Feasibility Protocol
- Lead sponsor
- Second Sight Medical Products
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- September 30, 2006
- Completion date
- December 31, 2019
- Enrollment
- 30 (actual)
- Sites
- 12
Conditions
As the registry lists them; a condition with its own page is linked.